CannaGrowth.com | Roth Conference
5537
archive,category,category-roth-conference,category-5537,ajax_fade,page_not_loaded,,vertical_menu_enabled,side_area_uncovered_from_content,qode-theme-ver-7.2,wpb-js-composer js-comp-ver-4.5.1,vc_responsive

Roth Conference

07 Mar Zynerba Pharmaceuticals to Present at 28th Annual ROTH Conference

DEVON, Pa., March 7, 2016 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will present at the 28th Annual ROTH Conference.

The post Zynerba...

Read More